{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:09Z","timestamp":1791288849905,"version":"4.3.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.14310\/horm.2002.1218","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T08:20:11Z","timestamp":1390983611000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management"],"prefix":"10.1007","volume":"8","author":[{"given":"Friedhelm","family":"Raue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Frank-Raue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,1]]},"reference":[{"key":"8010023_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000112114","volume":"68","author":"F Raue","year":"2007","unstructured":"Raue F, Frank-Raue K, 2007 Multiple Endocrine Neoplasia Type 2: 2007 Update. Horm Res 68: 101\u2013104.","journal-title":"Horm Res"},{"key":"8010023_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/thy.2005.15.531","volume":"15","author":"MA Kouvaraki","year":"2005","unstructured":"Kouvaraki MA, Shapiro SE, Perrier ND, et al, 2005 RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15: 531\u2013544.","journal-title":"Thyroid"},{"key":"8010023_CR3","first-page":"770","volume":"83","author":"I Berndt","year":"1998","unstructured":"Berndt I, Reuter M, Saller B, et al, 1998 A new hotspot for mutations in the RET proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 83: 770\u2013774.","journal-title":"J Clin Endocrinol Metab"},{"key":"8010023_CR4","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1210\/jc.2007-1005","volume":"92","author":"R Elisei","year":"2007","unstructured":"Elisei R, Romei C, Cosci B, et al, 2007 RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab 92: 4725\u20134729.","journal-title":"J Clin Endocrinol Metab"},{"key":"8010023_CR5","first-page":"273","volume":"53","author":"K Frank-Raue","year":"2007","unstructured":"Frank-Raue K, Rondot S, Schulze E, Raue F, 2007 Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Clin Lab 53: 273\u2013282.","journal-title":"Clin Lab"},{"key":"8010023_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cca.2006.01.029","volume":"370","author":"RA Hubner","year":"2006","unstructured":"Hubner RA, Houlston RS, 2006 Molecular advances in medullary thyroid cancer diagnosis. Clin Chim Acta 370: 2\u20138.","journal-title":"Clin Chim Acta"},{"key":"8010023_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/363458a0","volume":"363","author":"LM Mulligan","year":"1993","unstructured":"Mulligan LM, Kwok JBJ, Healey CS, et al, 1993 Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a (MEN 2A). Nature 363: 458\u2013469.","journal-title":"Nature"},{"key":"8010023_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, et al, 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851\u2013856.","journal-title":"Hum Mol Genet"},{"key":"8010023_CR9","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa012915","volume":"349","author":"A Machens","year":"2003","unstructured":"Machens A, Niccoli-Sire P, Hoegel J, et al, 2003 for the European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349: 1517\u20131525.","journal-title":"N Engl J Med"},{"key":"8010023_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","volume":"276","author":"C Eng","year":"1996","unstructured":"Eng C, Clayton D, Schuffenecker I, et al, 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276: 1575\u20131579.","journal-title":"JAMA"},{"key":"8010023_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archsurg.138.4.409","volume":"138","author":"L Yip","year":"2003","unstructured":"Yip L, Cote GL, Shapiro SE, et al, 2003 Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg 138: 409\u2013416.","journal-title":"Arch Surg"},{"key":"8010023_CR12","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1210\/jc.2005-0064","volume":"90","author":"A Machens","year":"2005","unstructured":"Machens A, Brauckhoff M, Holzhausen HJ, Thanh PN, Lehnert H, Dralle H, 2005 Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 90: 3999\u20134003.","journal-title":"J Clin Endocrinol Metab"},{"key":"8010023_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","volume":"142","author":"FJ Quayle","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R, Moley JF, 2007 Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142: 800\u2013805.","journal-title":"Surgery"},{"key":"8010023_CR14","first-page":"487","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, et al, and le Groupe d\u2019Etude des Tumeurs a Calcitonine 1998 Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. J Clin Endocrinol Metab 83: 487\u2013491.","journal-title":"J Clin Endocrinol Metab"},{"key":"8010023_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03215.x","volume":"69","author":"K Frank-Raue","year":"2008","unstructured":"Frank-Raue K, Machens A, Scheuba, C, Niederle B, Dralle H, Raue F, and the German MEN 2 Study Group 2008 Difference in the development of medullary thyroid carcinoma among carriers of RET mutations in codon 790 and 791. Clin Endocrinol 69: 259\u2013263.","journal-title":"Clin Endocrinol"},{"key":"8010023_CR16","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, et al, 2001 Guidelines for diagnosis and therapy of MEN Type 1 and Type 2. J Clin Endocrinol Metab 86: 5658\u20135671.","journal-title":"J Clin Endocrinol Metab"},{"key":"8010023_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/eje.1.02216","volume":"155","author":"K Frank-Raue","year":"2006","unstructured":"Frank-Raue K, Buhr H, Dralle H, et al, 2006 Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 155: 229\u2013236.","journal-title":"Eur J Endocrinol"},{"key":"8010023_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EJE-07-0817","volume":"158","author":"M Colombo-Benkmann","year":"2008","unstructured":"Colombo-Benkmann M, Li Z, Riemann B, et al, 2008 Characterization of the RET protooncogene transmem-brane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma. Eur J Endocrinol 158: 811\u2013816.","journal-title":"Eur J Endocrinol"},{"key":"8010023_CR19","first-page":"1814","volume":"63","author":"M Robledo","year":"2003","unstructured":"Robledo M, Gil L, Pollan M, et al, 2003 Polymorphisms G691S\/S904S of RET as genetic modifiers of MEN 2A. Cancer Research 63: 1814\u20131817.","journal-title":"Cancer Research"},{"key":"8010023_CR20","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1210\/jc.2004-2449","volume":"90","author":"A Cebrian","year":"2005","unstructured":"Cebrian A, Lesueur F, Martin S, et al, 2005 Polymorphisms in the initiators of RET (rearranged during transfection. signalling pathway and susceptibility to sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 90: 6268\u20136274.","journal-title":"J Clin Endocrinol Metab"},{"key":"8010023_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2265.2008.03230.x","volume":"69","author":"C Cardot-Bauters","year":"2008","unstructured":"Cardot-Bauters C, Leteurtre E, Leclerc L, et al, 2008 Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma? Clin Endocrinol 69: 506\u2013510.","journal-title":"Clin Endocrinol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1218\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T10:33:58Z","timestamp":1739097238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["8010023"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1218","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"1 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}